Related references
Note: Only part of the references are listed.Rapid rEcognition of COrticosteRoiD resistant or sensitive Sepsis (RECORDS): study protocol for a multicentre, placebo-controlled, biomarker-guided, adaptive Bayesian design basket trial
Jerome Fleuriet et al.
BMJ OPEN (2023)
Bayesian group sequential enrichment designs based on adaptive regression of response and survival time on baseline biomarkers
Yeonhee Park et al.
BIOMETRICS (2022)
Enrichment Bayesian design for randomized clinical trials using categorical biomarkers and a binary outcome
Valentin Vinnat et al.
BMC MEDICAL RESEARCH METHODOLOGY (2022)
Improved Doubly Robust Estimation in Learning Optimal Individualized Treatment Rules
Yinghao Pan et al.
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION (2021)
Optimal Individualized Decision Rules Using Instrumental Variable Methods
Hongxiang Qiu et al.
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION (2021)
A pragmatic adaptive enrichment design for selecting the right target population for cancer immunotherapies
Anh Nguyen Duc et al.
PHARMACEUTICAL STATISTICS (2021)
Ventilation management and clinical outcomes in invasively ventilated patients with COVID-19 (PRoVENT-COVID): a national, multicentre, observational cohort study
Michela Botta et al.
LANCET RESPIRATORY MEDICINE (2021)
Estimation of Optimal Individualized Treatment Rules Using a Covariate-Specific Treatment Effect Curve With High-Dimensional Covariates
Wenchuan Guo et al.
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION (2021)
Adaptive Enrichment Designs in Clinical Trials
Peter F. Thall
ANNUAL REVIEW OF STATISTICS AND ITS APPLICATION, VOL 8, 2021 (2021)
Hospital-Free Days: A Pragmatic and Patient-centered Outcome for Trials among Critically and Seriously Ill Patients
Catherine L. Auriemma et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)
Multi-stage adaptive enrichment trial design with subgroup estimation
Neha Joshi et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2020)
New clinical trial designs in the era of precision medicine: An overview of definitions, strengths, weaknesses, and current use in oncology
Perrine Janiaud et al.
CANCER TREATMENT REVIEWS (2019)
Effect of Selepressin vs Placebo on Ventilator- and Vasopressor-Free Days in Patients With Septic Shock: The SEPSIS-ACT Randomized Clinical Trial
Pierre-Francois Laterre et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Hydrocortisone plus Fludrocortisone for Adults with Septic Shock
D. Annane et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Random forests of interaction trees for estimating individualized treatment effects in randomized trials
Xiaogang Su et al.
STATISTICS IN MEDICINE (2018)
An unsupervised machine learning method for discovering patient clusters based on genetic signatures
Christian Lopez et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2018)
A subgroup cluster-based Bayesian adaptive design for precision medicine
Wentian Guo et al.
BIOMETRICS (2017)
Subgroup selection in adaptive signature designs of confirmatory clinical trials
Zhiwei Zhang et al.
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS (2017)
Precision medicine needs randomized clinical trials
Everardo D. Saad et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Modeling data with a truncated and inflated Poisson distribution
Min-Hsiao Tsai et al.
STATISTICAL METHODS AND APPLICATIONS (2017)
Bayesian population finding with biomarkers in a randomized clinical trial
Satoshi Morita et al.
BIOMETRICS (2017)
Liberal Manipulation of Ventilator Settings and Its Impact on Tracheostomy Rate and Ventilator-Free Days
Ariel M. Modrykamien et al.
RESPIRATORY CARE (2016)
Bayesian adaptive patient enrollment restriction to identify a sensitive subpopulation using a continuous biomarker in a randomized phase 2 trial
Shoichi Ohwada et al.
PHARMACEUTICAL STATISTICS (2016)
Hyperbaric oxygen brain injury treatment (HOBIT) trial: a multifactor design with response adaptive randomization and longitudinal modeling
Byron J. Gajewski et al.
PHARMACEUTICAL STATISTICS (2016)
Ranking treatments in frequentist network meta-analysis works without resampling methods
Gerta Ruecker et al.
BMC MEDICAL RESEARCH METHODOLOGY (2015)
Biomarker-based Bayesian randomized phase II clinical trial design to identify a sensitive patient subpopulation
Satoshi Morita et al.
STATISTICS IN MEDICINE (2014)
Bayesian hierarchical modeling of patient subpopulations: Efficient designs of Phase II oncology clinical trials
Scott M. Berry et al.
CLINICAL TRIALS (2013)
Adaptive enrichment with subpopulation selection at interim: Methodologies, applications and design considerations
Sue-Jane Wang et al.
CONTEMPORARY CLINICAL TRIALS (2013)
Designing a pilot sequential multiple assignment randomized trial for developing an adaptive treatment strategy
Daniel Almirall et al.
STATISTICS IN MEDICINE (2012)
Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial
Georgia Salanti et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
A method to estimate treatment efficacy among latent subgroups of a randomized clinical trial
Lily L. Altstein et al.
STATISTICS IN MEDICINE (2011)
Subgroup identification based on differential effect search-A recursive partitioning method for establishing response to treatment in patient subpopulations
Ilya Lipkovich et al.
STATISTICS IN MEDICINE (2011)
Subgroup identification from randomized clinical trial data
Jared C. Foster et al.
STATISTICS IN MEDICINE (2011)
Detecting qualitative interaction: A Bayesian approach
Emine Oezguer Bayman et al.
STATISTICS IN MEDICINE (2010)
Clinical Trial Designs for Predictive Biomarker Validation: One Size Does Not Fit All
Sumithra J. Mandrekar et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2009)
Clinical Trial Designs for Predictive Biomarker Validation: Theoretical Considerations and Practical Challenges
Sumithra J. Mandrekar et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Adaptive signature design: An adaptive clinical trial design for generating and prospectively testing a gene expression signature for sensitive patients
B Freidlin et al.
CLINICAL CANCER RESEARCH (2005)